Molecular genetic analysis of Isoniazid-resistant strains of Mycobacterium tuberculosis circulating in the Saratov region

Салина, Т. Ю.; Morozova, T. I.

doi:10.3103/s0891416813030075

Cited by 1 publication

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 This is of interest since there is evidence that geographic location influences on the strain-to-strain M. tuberculosis genetic variability. 13 , 14 , 15 In this context, current gold-standard molecular biomarkers to diagnose MDRTB might not be found at reasonable frequencies to guide anti-TB drug choice in neglected regions such as Brazil. Moreover, it is even possible that non-trivial mutations could turn out to be novel biomarkers for MDRTB diagnosis in such regions.…”

Section: Introductionmentioning

confidence: 99%

Detection of multidrug-resistant Mycobacterium tuberculosis strains isolated in Brazil using a multimarker genetic assay for katG and rpoB genes

Oliveira

Muniz-Sobrinho

Magno

et al. 2016

The Brazilian Journal of Infectious Diseases

View full text Add to dashboard Cite

Multidrug-resistant tuberculosis (MDRTB) is a serious world health problem that limits public actions to control tuberculosis, because the most used anti-tuberculosis first-line drugs fail to stop mycobacterium spread. Consequently, a quick detection through molecular diagnosis is essential to reduce morbidity and medical costs. Despite the availability of several molecular-based commercial-kits to diagnose multidrug-resistant tuberculosis, their diagnostic value might diverge worldwide since Mycobacterium tuberculosis genetic variability differs according to geographic location. Here, we studied the predictive value of four common mycobacterial mutations in strains isolated from endemic areas of Brazil. Mutations were found at the frequency of 41.9% for katG, 25.6% for inhA, and 69.8% for rpoB genes in multidrug-resistant strains. Multimarker analysis revealed that combination of only two mutations ("katG/S315T+rpoB/S531L") was a better surrogate of multidrug-resistant tuberculosis than single-marker analysis (86% sensitivity vs. 62.8%). Prediction of multidrug-resistant tuberculosis was not improved by adding a third or fourth mutation in the model. Therefore, rather than using diagnostic kits detecting several mutations, we propose a simple dual-marker panel to detect multidrug-resistant tuberculosis, with 86% sensitivity and 100% specificity. In conclusion, this approach (previous genetic study+analysis of only prevalent markers) would considerably decrease the processing costs while retaining diagnostic accuracy.

show abstract

Section: Introductionmentioning

confidence: 99%